期刊文献+

HPLC法测定注射用硫酸头孢噻利的含量

Content Determination of Cefoselis Sulfate for Injection by HPLC
原文传递
导出
摘要 目的:建立测定注射用硫酸头孢噻利含量的方法。方法:采用高效液相色谱法。色谱柱为Ultimate C18,流动相为甲醇-水(20∶80),柱温为30℃,流速为1mL·min-1,检测波长为257nm,进样量为20μL。结果:硫酸头孢噻利检测浓度线性范围为10.0~120.0μg·mL-1(r=0.9999);最低检测限为0.01μg·mL-1;低、中、高3种浓度硫酸头孢噻利的方法回收率分别为101.9%、100.3%、99.5%,日内RSD分别为1.07%、1.38%、1.40%,日间RSD分别为1.07%、2.58%、2.87%;3批样品平均标示含量为(96.5±1.7)%。结论:该方法简便、灵敏度高,适用于注射用硫酸头孢噻利的含量测定。 OBJECTIVE: To establish a method for the content determination of Cefoselis sulfate for injection. METHODS: HPLC method was adopted. The separation was performed on Ultimate Ct8 column and the column temperature was 30 ℃. The mobile phase consisted of methanol-water (20:80) with a flow rate at 1 mL.min^-1. The detection wavelength was set at 257 nm and injection volume was 20 μL. RESULTS: The linear range of cefoselis sulfate was 10.0~120.0 μg·mL^-1(r=0.999 9). The detection limit was 0.01 μg·mL^-1. The method recoveries were 101.9%, 100.3% and 99.5% at low, medium, high concentrations. The intra-day RSD were 1.07%, 1.38% and 1.40%, and inter-day RSD were 1.07%, 2.58% and 2.87%, respectively. The average content of 3 batches of Cefoselis sulfate for injection was (96.5 ± 1.7)%. CONCLUSION: The method is simple and sensitive for the content determination of Cefoselis sulfate for injection.
出处 《中国药房》 CAS CSCD 北大核心 2011年第9期846-847,共2页 China Pharmacy
关键词 高效液相色谱法 注射用硫酸头孢噻利 含量测定 HPLC Cefoselis sulfate for injection Content determination
  • 相关文献

参考文献6

二级参考文献15

  • 1沈凯,鲁亚苏,于作华,王强,周建新,李冬梅,赵志刚.人体血液及脑脊液中头孢吡肟浓度的HPLC测定方法研究[J].药物分析杂志,2005,25(3):263-266. 被引量:13
  • 2Neu HC,Chin NX,Huang HB.In vitro activity and β-lactamase stability of FK-037,a parenteral cephalosporin[J].Antimicrob Agents Chmother,1993 ;37:566-573.
  • 3Kato N,Kato H,Tanaka Y,et al.In vitro activity of FK-037,a new parenteral cephalosporin,against Anaerobic bacteria[J].Antimicrob Agents Chmother,1993 ;37:957-961.
  • 4Fu KP,Foleno BD,Lafredo SC,et al.In vitro and in vivo antibacte rial activities of FK-037,a novel parenteral broad-spectrum cephalosporin[J].Antimicrob Agents Chmother,1993 ;37:301-307.
  • 5Hirushi W,Yasushi Y,Takashi F,et al.Toxicity study of cefoselis sulfate(Ⅰ) single and thirteen-week intravenous toxicity study in rats[J].Iyakuhin Kenkyu,1995;26:561-577.
  • 6Hiroshi W,Hideo K,Takahiko N,et al.Toxicity study of cefoselis sulfate(Ⅱ) single and thirteen-week intravenous toxicity study in dogs[J].Iyalathin Kenkyu,1995 ;26:578-597.
  • 7馆田映一 平松启一 横田健.FK-037の细菌学检讨.Chemotherapy,1994,42(3):3-3.
  • 8Mikio S,Miyuki K,Yukio S,et al.Toxicity study of cefuselis sulfate(Ⅲ) reproductive and developmental toxicity study[J].lyakuhin Kenkyu,1995 ;26:773-787.
  • 9Wise R,Anderns JM,Oneill P,et al.Pharmacokinetics and distribution in tissue of FK-037,a new parenteral cephalosporin[J].Antimicrob Agents Chemother,1994 ;38:2369-2372.
  • 10National Institute of Health Sciences.Cefoselis sulfate[A].The Japanese Pharmacopoeia Fourteenth[M].Tokyo:The Ministry of Health,Labour and Welfare,2001:334-335.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部